• Legend
  • corporate
  • finance
  • sciences
  • Cellectis S.A. to Explore Possible Initial Public Offering of Calyxt, Inc.

    read more download
  • Cellectis to Present at the 2017 Annual Conference of the American Association for Cancer Research

    read more download
  • Servier and Pfizer announce FDA clearance of IND application for UCART19 in Adult Relapsed/Refractory Acute Lymphoblastic Leukemia

    read more
  • Five Additional Leading Physicians to Join Cellectis Clinical Advisory Board

    read more download
  • Cellectis Reports 4th Quarter and Full Year 2016 Financial Results

    read more download